Goldman Sachs Group »

Maplight Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $34M 1.9M 17.57

More positions owned by Goldman Sachs Group

Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Microsoft Corp CMN (MSFT)
Spdr S&p 500 Etf Tr CMN (SPY)
Tesla CMN (TSLA)
Alphabet CMN (GOOGL)
Amazon CMN (AMZN)
Broadcom CMN (AVGO)
Meta Platforms CMN (META)
Invesco Qqq Tr CMN (QQQ)
Vanguard Index Fds CMN (VOO)
Alphabet CMN (GOOG)
Ishares Tr CMN (IVV)
Eli Lilly & Co CMN (LLY)
Jpmorgan Chase & Co. CMN (JPM)

View all positions for Goldman Sachs Group

Top funds holding Maplight Therapeutics

T. Rowe Price Investment Management
Goldman Sachs Group
Vanguard Group
Geode Capital Management
State Street Corporation
Lazard Asset Management
Freestone Grove Partners
Bnp Paribas Investment Partners
Charles Schwab Investment Management
Marshall Wace
TD Asset Management
Bank of New York Mellon
Barclays
Wells Fargo & Company
UBS Group

View all funds holding Maplight Therapeutics